In future studies on mice or human subjects, some aspects still need to be clarified, including the effects of long-term use of ELE on intestinal health and gut microbiota regulation and a single compound or multiple compounds within the ELE exert protective effects from IBD and gut barrier injury through the “intestinal microbiota-bile acid-TGR5” axis. The gene discussed is GPBAR1; the disease is inflammatory bowel disease.